Moreover, MSC(AT)s were engineered with lentivirus encoding interleukin 2 (IL-2), a cytokine that stimulates anti-cancer immunity, for its EV-mediated delivery, aiming to reduce systemic toxicity. The gene discussed is IL2; the disease is cancer.